Application Study of Infusing Irritant Medications Through Midline Catheter Based on Real World Study
NCT ID: NCT05710835
Last Updated: 2023-02-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
1500 participants
OBSERVATIONAL
2022-12-01
2024-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Mild Sedation and Analgesia on Radial Artery Cannulation in Novice Residents
NCT05863455
Study to Investigate the Effect of Deferasirox on the Pharmacokinetics of Midazolam
NCT00427505
Pharmacokinetic Interaction Between Midazolam and ID-082 in Healthy Subjects
NCT03363984
Pharmacokinetics of Midazolam When Co-administered With HEC74647 and HEC110114
NCT05504876
A Safety and Efficacy Study of Dexmedetomidine in ICU Patients Requiring Continuous Sedation
NCT00216190
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
irritant medications group
Patients who used midline catheter to infuse irritant medications.
No interventions assigned to this group
nonirritant medications group
Patients who used midline catheter to infuse nonirritant medications.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients who had a midline catheter
Exclusion Criteria
* Patients who had both a midline catheter and a central vascular access device
14 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sir Run Run Shaw Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Zhao Linfang
assitant nursing director
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Linfang Zhao
Role: PRINCIPAL_INVESTIGATOR
Sir Run Run Shaw Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Linfang Zhao
Hangzhou, Zhejiang, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Adams DZ, Little A, Vinsant C, Khandelwal S. The Midline Catheter: A Clinical Review. J Emerg Med. 2016 Sep;51(3):252-8. doi: 10.1016/j.jemermed.2016.05.029. Epub 2016 Jul 5.
Qin KR, Pittiruti M, Nataraja RM, Pacilli M. Long peripheral catheters and midline catheters: Insights from a survey of vascular access specialists. J Vasc Access. 2021 Nov;22(6):905-910. doi: 10.1177/1129729820966226. Epub 2020 Oct 20.
Gorski LA, Hadaway L, Hagle ME, Broadhurst D, Clare S, Kleidon T, Meyer BM, Nickel B, Rowley S, Sharpe E, Alexander M. Infusion Therapy Standards of Practice, 8th Edition. J Infus Nurs. 2021 Jan-Feb 01;44(1S Suppl 1):S1-S224. doi: 10.1097/NAN.0000000000000396. No abstract available.
Prasanna N, Yamane D, Haridasa N, Davison D, Sparks A, Hawkins K. Safety and efficacy of vasopressor administration through midline catheters. J Crit Care. 2021 Feb;61:1-4. doi: 10.1016/j.jcrc.2020.09.024. Epub 2020 Oct 2.
Anderson J,Greenwell A,Louderback J,et al.Comparison of Outcomes of Extended Dwell/Midline Peripheral Intravenous Catheters and Peripherally Inserted Central Catheters in Children[J].Journal of Vascular Access,2016,21(3): 158-164.
Knottnerus JA, Tugwell P. Real world research. J Clin Epidemiol. 2010 Oct;63(10):1051-2. doi: 10.1016/j.jclinepi.2010.08.001. No abstract available.
Mermel LA, Parenteau S, Tow SM. The risk of midline catheterization in hospitalized patients. A prospective study. Ann Intern Med. 1995 Dec 1;123(11):841-4. doi: 10.7326/0003-4819-123-11-199512010-00005.
Hallam C, Weston V, Denton A, Hill S, Bodenham A, Dunn H, Jackson T. Development of the UK Vessel Health and Preservation (VHP) framework: a multi-organisational collaborative. J Infect Prev. 2016 Mar;17(2):65-72. doi: 10.1177/1757177415624752. Epub 2016 Jan 10.
Alexandrou E,Ramjan LM,Spencer T,et al.The use of midline catheters in the adult acute care setting-clinical implications and recommendations for practice[J]. Journal of the Association for Vascular Access,2011,16(1): 35-41.
Marsh N, Webster J, Larson E, Cooke M, Mihala G, Rickard CM. Observational Study of Peripheral Intravenous Catheter Outcomes in Adult Hospitalized Patients: A Multivariable Analysis of Peripheral Intravenous Catheter Failure. J Hosp Med. 2018 Feb 1;13(2):83-89. doi: 10.12788/jhm.2867. Epub 2017 Oct 18.
Anderson NR. Midline catheters: the middle ground of intravenous therapy administration. J Infus Nurs. 2004 Sep-Oct;27(5):313-21. doi: 10.1097/00129804-200409000-00005.
O'Grady NP, Alexander M, Burns LA, Dellinger EP, Garland J, Heard SO, Lipsett PA, Masur H, Mermel LA, Pearson ML, Raad II, Randolph AG, Rupp ME, Saint S; Healthcare Infection Control Practices Advisory Committee. Guidelines for the prevention of intravascular catheter-related infections. Am J Infect Control. 2011 May;39(4 Suppl 1):S1-34. doi: 10.1016/j.ajic.2011.01.003. No abstract available.
Mushtaq A, Navalkele B, Kaur M, Krishna A, Saleem A, Rana N, Gera S, Chandramohan S, Surapaneni M, Chopra T. Comparison of complications in midlines versus central venous catheters: Are midlines safer than central venous lines? Am J Infect Control. 2018 Jul;46(7):788-792. doi: 10.1016/j.ajic.2018.01.006. Epub 2018 Mar 7.
DeVries M, Lee J, Hoffman L. Infection free midline catheter implementation at a community hospital (2 years). Am J Infect Control. 2019 Sep;47(9):1118-1121. doi: 10.1016/j.ajic.2019.03.001. Epub 2019 Apr 30.
Sharp R, Esterman A, McCutcheon H, Hearse N, Cummings M. The safety and efficacy of midlines compared to peripherally inserted central catheters for adult cystic fibrosis patients: a retrospective, observational study. Int J Nurs Stud. 2014 May;51(5):694-702. doi: 10.1016/j.ijnurstu.2013.09.002. Epub 2013 Sep 14.
Lisova K, Hromadkova J, Pavelkova K, Zauska V, Havlin J, Charvat J. The incidence of symptomatic upper limb venous thrombosis associated with midline catheter: Prospective observation. J Vasc Access. 2018 Sep;19(5):492-495. doi: 10.1177/1129729818761276. Epub 2018 Mar 16.
Dickson HG, Flynn O, West D, Alexandrou E, Mifflin N, Malone M. A Cluster of Failures of Midline Catheters in a Hospital in the Home Program: A Retrospective Analysis. J Infus Nurs. 2019 Jul/Aug;42(4):203-208. doi: 10.1097/NAN.0000000000000330.
Cawcutt KA, Hankins RJ, Micheels TA, Rupp ME. Optimizing vascular-access device decision-making in the era of midline catheters. Infect Control Hosp Epidemiol. 2019 Jun;40(6):674-680. doi: 10.1017/ice.2019.49. Epub 2019 Mar 29.
Nielsen EB, Antonsen L, Mensel C, Milandt N, Dalgaard LS, Illum BS, Arildsen H, Juhl-Olsen P. The efficacy of midline catheters-a prospective, randomized, active-controlled study. Int J Infect Dis. 2021 Jan;102:220-225. doi: 10.1016/j.ijid.2020.10.053. Epub 2020 Oct 28.
Elli S, Pittiruti M, Pigozzo V, Cannizzo L, Giannini L, Siligato A, Rondelli E, Foti G, Lucchini A. Ultrasound-guided tip location of midline catheters. J Vasc Access. 2020 Sep;21(5):764-768. doi: 10.1177/1129729820907250. Epub 2020 Feb 28.
Caparas JV, Hu JP. Safe administration of vancomycin through a novel midline catheter: a randomized, prospective clinical trial. J Vasc Access. 2014 Jul-Aug;15(4):251-6. doi: 10.5301/jva.5000220. Epub 2014 Apr 8.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IVTEAM202301
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.